Joan Ortiz-Punet
Barcelona, CT 08036, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
CD229 (Ly9) a Novel Biomarker for B-Cell Malignancies and Multiple Myeloma.
Journal: Cancers
Published: March 10, 2022
Standardization of Workflow and Flow Cytometry Panels for Quantitative Expression Profiling of Surface Antigens on Blood Leukocyte Subsets: An HCDM CDMaps Initiative.
Journal: Frontiers in immunology
Published: December 02, 2021
Autoimmune B Cell Repertoire in a Mouse Model of Sjögren's Syndrome.
Journal: Frontiers in immunology
Published: February 10, 2021
Cytomegalovirus restricts ICOSL expression on antigen-presenting cells disabling T cell co-stimulation and contributing to immune evasion.
Journal: eLife
Published: May 27, 2020
Ly9 (CD229) Antibody Targeting Depletes Marginal Zone and Germinal Center B Cells in Lymphoid Tissues and Reduces Salivary Gland Inflammation in a Mouse Model of Sjögren's Syndrome.
Journal: Frontiers in immunology
Published: August 03, 2018
Corrigendum: Monitoring T-Cell Responses in Translational Studies: Optimization of Dye-Based Proliferation Assay for Evaluation of Antigen-Specific Responses.
Journal: Frontiers in immunology
Published: January 29, 2018
Monitoring T-Cell Responses in Translational Studies: Optimization of Dye-Based Proliferation Assay for Evaluation of Antigen-Specific Responses.
Journal: Frontiers in immunology
Published: August 23, 2017
Ly9 (SLAMF3) receptor differentially regulates iNKT cell development and activation in mice.
Journal: European journal of immunology
Published: January 05, 2017
Monitoring CD49d Receptor Occupancy: A Method to Optimize and Personalize Natalizumab Therapy in Multiple Sclerosis Patients.
Journal: Cytometry. Part B, Clinical cytometry
Published: December 13, 2016
Showing 1-9 of 9
Last Updated: 09/26/2026